Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04074616 · ClinicalTrials.gov registry record · NA
Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation
A NA study of Neurogenic Bladder and Chronic Spinal Cord Injury, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04074616 is a NA study of Neurogenic Bladder and Chronic Spinal Cord Injury that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 50 participants, below the 90-participant average among 16 other Neurogenic Bladder trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04074616, a NA study of Neurogenic Bladder and Chronic Spinal Cord Injury, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the efficacy of home transcutaneous tibial nerve stimulation (TTNS) in spinal cord injury(SCI) and to determine the impact on quality of life using TTNS at home
Conditions Studied
Interventions
- DEVICE High Dose
- DEVICE Low dose
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-11-19 |
| Est. Completion | 2023-04-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04074616
The ClinicalTrials.gov registry entry for NCT04074616 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90-participant average among 16 other Neurogenic Bladder trials with a reported enrollment target (44% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Neurogenic Bladder appearing as the primary indexed condition, and to 2 interventions - of which High Dose is the first listed.
NCT04074616 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04074616 about?
NCT04074616 is a clinical study titled "Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation". The purpose of this study is to determine the efficacy of home transcutaneous tibial nerve stimulation (TTNS) in spinal cord injury(SCI) and to determine the impact on quality of life using TTNS at home
What is the current status of trial NCT04074616?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2019-11-19. Estimated completion is 2023-04-20.
What conditions does trial NCT04074616 study?
This clinical trial studies the following conditions: Neurogenic Bladder, Chronic Spinal Cord Injury.
What interventions are being tested in trial NCT04074616?
The interventions under investigation include: High Dose (DEVICE), Low dose (DEVICE).
Who is sponsoring clinical trial NCT04074616?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04074616 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurogenic Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
RECRUITING · NA
-
Vascularized Composite Bladder Allograft Transplantation
RECRUITING · NA
-
Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healthcare Encounters and Quality of Life
RECRUITING · NA
-
Electrical Stimulation for Continence After Spinal Cord Injury
ACTIVE NOT RECRUITING · NA
-
Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study
COMPLETED · NA
-
Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation
RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.